Apolipoprotein D Inhibits Platelet-Derived Growth Factor-BB-Induced Vascular Smooth Muscle Cell Proliferated by Preventing Translocation of Phosphorylated Extracellular Signal Regulated Kinase 1/2 to the Nucleus

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 12, 2003, Pages 2172-2177

  Sarjeant, Jennifer M ^a   Lawrie, Allan ^d   Kinnear, Caroline ^a   Yablonsky, Shmuel ^a   Leung, Wesley ^a   Massaeli, Hamid ^a   Prichett, Wendy ^b   Veinot, John P ^e   Rassart, Eric ^c   Rabinovitch, Marlene ^a,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CCSR ^*

Author keywords

Apolipoprotein D; Extracellular signal regulated kinase phosphorylation and nuclear translocation; Fibroblast growth factor 2; Platelet derived growth factor BB; Proliferation; Vascular smooth muscle cells

Indexed keywords

APOLIPOPROTEIN D; FIBROBLAST GROWTH FACTOR 2; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL CELL; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN A10; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FETUS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LAMB; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; APOLIPOPROTEINS; APOLIPOPROTEINS D; ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; CORONARY VESSELS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN TRANSPORT; RATS; RNA, MESSENGER; SHEEP; TRANSFECTION;

EID: 10744219548     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000100404.05459.39     Document Type: Article

References (34)

1. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190:300-309.
2. Homma Y, Sakamoto H, Tsunoda M, Aoki M, Takenawa T, Ooyama T. Evidence for involvement of phospholipase C-gamma 2 in signal transduction of platelet-derived growth factor in vascular smooth-muscle cells. Biochem J. 1993;290:649-653.
3. Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation, 2001;104:2376-2383.
4. Sirtori CR, Calabresi L, Franceschini G. Recombinant apolipoproteins for the treatment of vascular diseases. Atherosclerosis. 1999;142:29-40.
5. Do Carmo S, Seguin D, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem. 2002;277: 5514-5523.
6. Ishigami M, Swertfeger DK, Granholm NA, Hui DY. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem. 1998;273:20156-20161.
7. Sivamurthy N, Stone DH, Logerfo FW, Quist WC. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells. J Vasc Surg. 2001;34:716-723.
8. McConathy WJ, Alaupovic P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett. 1973;37:178-182.
9. Blanco-Vaca F, Via DP, Yang CY, Massey JB, Pownall HJ. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J Lipid Res. 1992;33:1785-1796.
10. James RW, Martin B, Pometta D, Grab B, Suenram A. Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis. 1986;60:49-53.
11. Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E. Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett. 1991;290:139-141.
12. Lopez-Boado YS, Tolivia J, Lopez-Otin C. Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J Biol Chem. 1994;269: 26871-26878.
13. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 1999;18:664-674.
14. Aplin AE, Stewart SA, Assoian RK, Juliano RL. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol. 2001;153:273-282.
15. Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem. 2002;277:9268-9277.
16. Rabinovitch M, Beharry S, Bothwell T, Jackowski G. Qualitative and quantitative differences in protein synthesis comparing fetal lamb ductus arteriosus endothelium and smooth muscle with cells from adjacent vascular sites. Dev Biol. 1988;130:250-258.
17. Libby P, O'Brien KV. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol. 1983;115:217-223.
18. Terrisse L, Marcoux K, Carmo SD, Brissette L, Milne R, Rassart E. Structure-function relationships of human apolipoprotein D an immunochemical analysis. Life Sci. 2001;70:629-638.
19. Rao RS, Miano JM, Olson EN, Seidel CL. The A10 cell line: a model for neonatal, neointimal, or differentiated vascular smooth muscle cells? Cardiovasc Res. 1997;36:118-126.
20. Templeton DM, Zhao Y, Fan MY. Heterogeneity in the response of vascular smooth muscle to heparin: altered signaling in heparin-resistant cells. Cardiovasc Res. 2000;45:503-512.
21. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
22. Diez-Itza I, Vizoso F, Merino AM, Sanchez LM, Tolivia J, Fernandez J, Ruibal A, Lopez-Otin C. Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol. 1994;144:310-320.
23. Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Cancer Res. 1999; 59:2384-2394.
24. Provost PR, Villeneuve L, Weech PK, Milne RW, Marcel YL, Rassart E. Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J Lipid Res. 1991;32:1959-1970.
25. Smith KM, Lawn RM, Wilcox JN. Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. J Lipid Res. 1990;31:995-1004.
26. Sanchez D, Ganfornina MD, Martinez S. Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis. Mech Dev. 2002;110:225-229.
27. Hu CY, Ong WY, Sundaram RK, Chan C, Patel SC. Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex. J Neurocytol. 2001;30:209-218.
28. Yang Z, Madinova A, Kozai T, Joch H, Aebi U, Luscher TF. Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth. Cardiovasc Res. 2002;53: 227-231.
29. Jackson TA, Koterwas DM, Morgan MA, Bradford AP. Fibroblast growth factors regulate PRL transcription via an atypical Rac-dependent signaling pathway. Mol Endocrinol. 2003;10:1921-1930.
30. Ramet ME, Ramet M, Lu Q, Nickerson M, Savolainen MJ, Malzone A, Karas RH. High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J Am Coll Cardiol. 2003;41:2288-2297.
31. Hirsch E, Barberis L, Brancaccio M, Azzolino O, Xu D, Kyriakis JM, Silengo L, Giancotti FG, Tarone G, Fassler R, Altruda F. Defective Rac-mediated proliferation and survival after targeted mutation of the betal integrin cytodomain. J Cell Biol. 2002;157:481-492.
32. Impey S, Obrietan K, Wong ST, Poser S, Yano S, Wayman G, Deloulme JC, Chan G, Storm DR. Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron. 1998;21:869-883.
33. Pursiheimo JP, Jalkanen M, Tasken K, Jaakkola P, Involvement of protein kinase A in fibroblast growth factor-2-activated transcription. Proc Natl Acad Sci U S A. 2000;97:168-173.
34. Pouyssegur J, Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem. 2003;270:3291-3299.